The aim of this study is to examine for the first time the expression of AGR2 in specimens of primary breast carcinomas so as to assess its relationship with other tumour variables and with patients' survival in a group of patients treated by hormonal therapy. This evidence concerns the gene AGR2 and breast carcinoma.